Merck, a global pharmaceutical company, leverages AWS services to address false rejects in drug inspection. Using AWS Glue, Amazon Kinesis, Amazon Redshift, and Amazon SageMaker, Merck ingests and analyzes real-time data from manufacturing processes and inspection machines. They employ generative AI approaches like GANs and Variational Autoencoders to develop synthetic defect image data. This solution has reduced false rejects by over 50%, improving product availability and enabling rapid root cause analysis. Merck's innovative use of AWS services demonstrates the power of AI/ML in advancing healthcare and improving patient access to life-saving medicines.